Live·Verified funding discovery · 2026.2

874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640

△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA

Hans Bishop

angel

Capital ownerEcosystem influencer

About

Hans Bishop is a biotech entrepreneur and executive best known for co-founding Juno Therapeutics and serving as its CEO until its 2018 sale to Celgene. He is currently President, Founder and Board Co-Chair of Altos Labs and Chairman of Sana Biotechnology, and he previously served as CEO of GRAIL. Public sources also show him making angel-style startup investments, including Terrain Biosciences.

Areas of interest

biotechcell therapycancer immunotherapylongevitycell rejuvenationRNA therapeuticsAI for biologygenomics